Navigation Links
Drug for pediatric brain cancer

Scientists from Canada are reporting promising results from a study of a new drug for children with acute brain tumors. The drug fotemustine, when delivered intravenously every three weeks, was found to be partially effective in shrinking the tumors.
//
The drug is one of a group of drugs called chloroethylnitrosoureas. They were first discovered in 1959 and have since been shown to help shrink solid tumors, including cancerous brain tumors. Studies in adults with brain tumors showed fotemustine was at least partially effective in about 20 percent of patients.

In this study, researchers from the Hospital for Sick Children in Toronto tested the drug in 14 children under age 20 with various types of malignant brain tumors, including primary tumors and tumors caused by cancer that had spread to the brain. All of the children had exhausted conventional.

Together the children received a total of 40 doses of the medication. Images were then taken to measure the response to the drug. Three children demonstrated a positive response to the drug, with one showing a 50 percent or greater reduction in the tumor and the other two showing 25% to 50% reductions. The drug was generally well-tolerated by the children.

The researchers believe these results indicate a need for further study of fotemustine for the treatment of pediatric brain tumors and suggest the need for more studies involving the drug alone or possibly in combination with other agents.


'"/>




Page: 1

Related medicine news :

1. Medicis Pharmaceutical company enters pediatric market
2. Drug for pediatric brain cancer
3. Lorenzos oil for prevention of pediatric neurological disorder
4. British pediatricians urge parents to administer MMR to children
5. Multi billion-dollar suit filed against cell phone firm for causing brain tumours
6. Two doctors suspended for wrong brain surgery
7. The brain loves a surprise
8. Increase in sugar...decrease in brain function!!!
9. Alcohol shrinks brain
10. Roller coaster takes brain for a big ride!!
11. The big brain in suicides
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... ... March 27, 2017 , ... M&S ... Certificate of Conformity for the Smart System® 20/20. CE Certification builds upon M&S's ... standards and specifications such as ANSI, ISO and proven test methods used in ...
(Date:3/27/2017)... PA (PRWEB) , ... March 27, 2017 , ... ... business simulation -centric training, today announced the launch of a new research ... strategy, having the skills needed to execute that strategy, and the actual success ...
(Date:3/27/2017)... ... March 27, 2017 , ... According to the American Cancer ... stages, is more than 95%. Once the cancer spreads to other organs, bones, or ... find out how to avoid this latter group, tune in to Lifestyle Magazine ...
(Date:3/27/2017)... Texas (PRWEB) , ... March 27, 2017 , ... ... at the GTEC Orange facility from 8:00am-10:00am on Monday, April 3rd to commemorate ... and will be an opportunity for area-residents to celebrate two great years while ...
(Date:3/25/2017)... PA (PRWEB) , ... March 25, 2017 , ... Getting ... as a public relations partner. , All through the year, Garden Media aims ... press releases, working with key influencers and pitching client’s key messages to ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017  ImMAGE Biotherapeutics (OTCMKTS: ... immunotherapy successfully passed early toxicology and efficacy studies. The ... to target a specific protein, MAGE A, in an ... breast cancer. After 4 weeks of ... to show very little toxicity in a full toxicology ...
(Date:3/27/2017)... , March 27, 2017  Sanderling Ventures, portfolio ... Ethicon, a division of Johnson & Johnson. Torax manufactures ... the treatment of gastro-esophageal reflux disease (GERD). The ... (MSA) technology and the procedure is currently available ... Torax Medical was founded by Sanderling Ventures, ...
(Date:3/27/2017)... TEL AVIV, Israel , March 27, 2017 ... focused on oncology and immunology, announced today that AGI-134, an ... recently announced acquisition of Agalimmune Ltd., will be featured at ... Meeting in Washington, DC to ... ...
Breaking Medicine Technology: